share_log

Morgan Stanley Upgrades Evotec to Overweight, Raises Price Target to $16

Benzinga ·  Jun 23, 2023 05:46

Morgan Stanley analyst James Quigley upgrades Evotec (NASDAQ:EVO) from Equal-Weight to Overweight and raises the price target from $12 to $16.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment